261 related articles for article (PubMed ID: 20376098)
21. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions.
Kim JH; Kim YH; Kim S; Noh EB; Kim SE; Vorobyev A; Schmidt E; Zillikens D; Kim SC
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e224-30. PubMed ID: 22731917
[TBL] [Abstract][Full Text] [Related]
22. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
[TBL] [Abstract][Full Text] [Related]
23. A novel missense mutation in the COL7A1 gene causes epidermolysis bullosa pruriginosa.
Shi BJ; Feng J
Clin Exp Dermatol; 2009 Dec; 34(8):e975-8. PubMed ID: 19486043
[TBL] [Abstract][Full Text] [Related]
24. A glycine substitution in the COL7A1 gene causes mild RDEB in a Pakistani family.
Kraemer L; Wajid M; Christiano AM
Eur J Dermatol; 2006; 16(6):615-9. PubMed ID: 17229600
[TBL] [Abstract][Full Text] [Related]
25. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
[TBL] [Abstract][Full Text] [Related]
26. Natural gene therapy in dystrophic epidermolysis bullosa.
van den Akker PC; Nijenhuis M; Meijer G; Hofstra RM; Jonkman MF; Pasmooij AM
Arch Dermatol; 2012 Feb; 148(2):213-6. PubMed ID: 22004882
[TBL] [Abstract][Full Text] [Related]
27. X-linked ichthyosis along with recessive dystrophic epidermolysis bullosa in the same patient.
Hernández-Martín A; Cuadrado-Corrales N; Ciria-Abad S; Arias-Palomo D; Mascaró-Galy JM; Escámez MJ; García M; Del Río M; Torrelo A; González-Sarmiento R
Dermatology; 2010; 221(2):113-6. PubMed ID: 20523032
[TBL] [Abstract][Full Text] [Related]
28. A case of recessive dystrophic epidermolysis bullosa caused by compound heterozygous mutations in the COL7A1 gene.
Suzuki S; Shimomura Y; Yamamoto Y; Kariya N; Shibuya M; Ito M; Fujiwara H
Br J Dermatol; 2006 Oct; 155(4):838-40. PubMed ID: 16965439
[No Abstract] [Full Text] [Related]
29. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
30. A -96C-->T mutation in the promoter of the collagen type VII gene (COL7A1) abolishing transcription in a patient affected by recessive dystrophic epidermolysis bullosa.
Gardella R; Barlati S; Zoppi N; Tadini G; Colombi M
Hum Mutat; 2000 Sep; 16(3):275. PubMed ID: 10980546
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel type VII collagen gene mutations resulting in severe recessive dystrophic epidermolysis bullosa.
Massé M; Cserhalmi-Friedman PB; Falanga V; Celebi JT; Martinez-Mir A; Christiano AM
Clin Exp Dermatol; 2005 May; 30(3):289-93. PubMed ID: 15807692
[TBL] [Abstract][Full Text] [Related]
32. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
[TBL] [Abstract][Full Text] [Related]
33. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
[TBL] [Abstract][Full Text] [Related]
34. High frequency of the 425A-->G splice-site mutation and novel mutations of the COL7A1 gene in central Europe: significance for future mutation detection strategies in dystrophic epidermolysis bullosa.
Csikós M; Szocs HI; Lászik A; Mecklenbeck S; Horváth A; Kárpáti S; Bruckner-Tuderman L
Br J Dermatol; 2005 May; 152(5):879-86. PubMed ID: 15888141
[TBL] [Abstract][Full Text] [Related]
35. Compound heterozygosity in sibling patients with recessive dystrophic epidermolysis bullosa associated with a mild phenotype.
Shibusawa Y; Negishi I; Ishikawa O
Int J Dermatol; 2006 Mar; 45(3):302-5. PubMed ID: 16533235
[TBL] [Abstract][Full Text] [Related]
36. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.
Odorisio T; Di Salvio M; Orecchia A; Di Zenzo G; Piccinni E; Cianfarani F; Travaglione A; Uva P; Bellei B; Conti A; Zambruno G; Castiglia D
Hum Mol Genet; 2014 Aug; 23(15):3907-22. PubMed ID: 24599399
[TBL] [Abstract][Full Text] [Related]
37. Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico.
Saeidian AH; Youssefian L; Moreno Trevino MG; Fortuna G; Vahidnezhad H; Atanasova VS; Uitto J; Salas-Alanis JC; South AP
Clin Exp Dermatol; 2018 Jul; 43(5):579-584. PubMed ID: 29473190
[TBL] [Abstract][Full Text] [Related]
38. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
[TBL] [Abstract][Full Text] [Related]
39. Immunofluorescence studies using skin sections of recessive dystrophic epidermolysis bullosa patients indicated that the antigen of anti-p200 pemphigoid is not a fragment of type VII collagen.
Liu Y; Shimizu H; Hashimoto T
J Dermatol Sci; 2003 Aug; 32(2):125-9. PubMed ID: 12850304
[TBL] [Abstract][Full Text] [Related]
40. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa.
Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW
J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
